Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2010
06/23/2010CN101744912A Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof
06/23/2010CN101744911A Traditional Chinese medicine composition with function of reducing blood pressure and preparation method thereof
06/23/2010CN101744907A Applications of Chinese medicinal composition to preparation of medicament for treating hyperlipemia with hepatic lesion
06/23/2010CN101744905A Applications of Chinese medicinal composition to preparation of medicament for treating pulmonary heart disease
06/23/2010CN101744899A Traditional Chinese medicine paste for treating chemotherapy phlebitis vasospasm stage and preparation
06/23/2010CN101744892A Method for measuring the content of danshinolic acid B in the radix polygoni multiflori and radix salviae miltiorrhizae dripping pills
06/23/2010CN101744891A Method for measuring the content of bornyl alcohol in the radix polygoni multiflori and radix salviae miltiorrhizae dripping pills
06/23/2010CN101744886A Method for extracting high-purity schisandra total lignan
06/23/2010CN101744880A Quality control method for total salvianolic acid injection
06/23/2010CN101744878A Water-soluble salvia miltiorrhiza extractive, preparation and application thereof
06/23/2010CN101744877A Selfheal quality control method
06/23/2010CN101744867A Soft capsules for treating apoplexy and preparation method thereof
06/23/2010CN101744863A Persimmon leaf extract preparation, preparing method thereof and application thereof
06/23/2010CN101744852A Preparation method of acanthopanax effervescent tablet and products thereof
06/23/2010CN101744847A Agaricus compound polysaccharide capsule preparation method
06/23/2010CN101744845A Chlorella extractive composition and preparation method thereof
06/23/2010CN101744842A Lipidosome Chinese traditional medicine membranous plaster
06/23/2010CN101744822A Medicinal composition for treating hemorrhoids
06/23/2010CN101744821A Application of pentoxifylline in treatment of anorectal disease
06/23/2010CN101744813A Compound amlodipine and valsartan solid preparation and preparation method thereof
06/23/2010CN101744807A Epigallocatechin-3-gallate pharmaceutical composition and freeze-dried powder injection thereof
06/23/2010CN101744806A Application of pinocembrin raceme in preparation of medicals for cerebral apoplexy
06/23/2010CN101744787A Controlled release composite containing vinpocetine
06/23/2010CN101744786A Prescription of felodipine sustained-release tablets and preparation method
06/23/2010CN101744784A Double-layer slow-release tablet with puerarin derivatives and preparation method thereof
06/23/2010CN101744783A Isosorbide mononitrate controlled release tablet and preparation method thereof
06/23/2010CN101744774A Method for preparing ginkgolide B lyophilized powder injection
06/23/2010CN101744285A Method for preparing emulsified and gelatinized functional fatty acid carrier
06/23/2010CN101743963A Mosquito repellent and preparation method thereof
06/23/2010CN101474159B Creatine phosphate sodium microballoon lyophilized preparation and method for producing the same
06/23/2010CN101307025B Chuanxiong alcohol carnitine ester compounds
06/23/2010CN101292970B Use of 3,4-dihydroxy coffee acyl group tartaric acid in preparing medicaments for coronary disease
06/23/2010CN101215283B Secalonic acid A compound and its preparing method and application in preparing neuron cell protection medicament
06/23/2010CN101204440B Medicine for varicosity
06/23/2010CN101199614B Medicament for treating vasculitic
06/23/2010CN101195016B Medicament for treating apoplexy and technique of preparing the same
06/23/2010CN101104015B Olive soft capsule raw material formulation and its preparation technology
06/23/2010CN101011091B Fermented tea, extract of fermented tea, composition for inhibiting elevation of blood sugar value, and beverage and foodstuff
06/22/2010US7741483 2-[2-ethoxyl-5-(4-ethylpiperazinyl-1-sulfonyl)phenyl]-5-methyl-7-n-propyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one, used for the treatment and/or prevention of sexual disorders such as erectile dysfunction
06/22/2010US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation
06/22/2010US7741434 High-affinity antagonists of ELR-CXC chemokines
06/22/2010US7741349 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer'
06/22/2010US7741346 Vision defects; anticancer agents; antitumor agents
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders
06/22/2010US7741269 Exendins and exendin agonists for weight reduction and obesity
06/22/2010US7741080 elucidate the functional mechanism of adipocyte hypertrophy-dependent suppression of adiponectin production; identifies factors that can increase the expression of adiponectin gene; provides adiponectin expression-inducing agents; metabolic or heart diseases
06/22/2010US7741078 Heparin-binding protein modified with heparan sulfate sugar chains, process for producing the same and pharmaceutical compositions containing the same
06/22/2010US7740885 rich in polyunsaturated fatty acids such as linolenic acid, eicosapentaenoic acid, docosahexaenoic acid and antioxidant; cardiovascular diseases
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010US7740830 Imaging, diagnosis and treatment of disease
06/22/2010CA2586538C Nitroxy steroids
06/22/2010CA2552218C Left-side glucose lipid a analogue
06/22/2010CA2500575C New derivatives of 4-oxo-4,6,7,8-tetrhydro-pyrrolo[1,2-a]pyrazine-6-carbonxamides, their preparation process and the pharmaceutical compositions that contain them
06/22/2010CA2492161C New derivatives of fluorinated benzothiadiazines, the process for preparing them and the pharmaceutical compounds that contain them
06/22/2010CA2485479C New 2-(.alpha.-hydroxypentyl) benzoates, their preparations and their uses
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2469225C Citric acid salt of 4-(3,4-dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one and pharmaceutical compositions thereof
06/22/2010CA2444489C Benzimidazolone compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2441398C Lipid lowering biphenylcarboxamides
06/22/2010CA2439430C Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity
06/22/2010CA2425696C Coated medical devices for the treatment of vascular disease
06/22/2010CA2411716C 1,3,8-triaza-spiro [4.5] decan derivatives
06/22/2010CA2410408C 2-aminoalkylthieno[2,3-d]pyrimidines
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/22/2010CA2401655C Cardioprotective phosphonates and malonates
06/22/2010CA2401593C Infusion packet with useful and decorative elements, support member, delivery system and method
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/22/2010CA2382355C Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
06/22/2010CA2216963C Tie-2 ligands, methods of making and uses thereof
06/17/2010WO2010068866A2 Therapeutic particles suitable for parenteral administration and methods of making and using same
06/17/2010WO2010068815A2 Compositions and methods for treating cellular proliferative disorders
06/17/2010WO2010068710A2 Kinase inhibitor compounds
06/17/2010WO2010068461A1 Co-administration of ranolazine and cardiac glycosides
06/17/2010WO2010068308A1 Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease
06/17/2010WO2010068242A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/17/2010WO2010068056A2 Composition containing glucosamine or glucosamine derivative for preventing or treating hemadostenosis and restenosis
06/17/2010WO2010067755A1 Therapeutic agent for hypertension, method for treating hypertension, method for diagnosing hypertension, and method for screening therapeutic agent for hypertension
06/17/2010WO2010066931A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
06/17/2010WO2010066815A2 Encapsulating system for cest imaging with chelate q greater than or equal to 2
06/17/2010WO2010066239A1 Inhibitors of dimethylarginine dimethylaminohydrolase
06/17/2010WO2010066199A1 Use of racemates of pinocembrin in preparing medicaments for treating stroke
06/17/2010WO2010066125A1 A short peptide, preparation and uses thereof
06/17/2010WO2010066028A1 3,4 - substituted piperidine derivatives as renin inhibitors
06/17/2010WO2010046869A3 Tetrahydronaphthalene compounds
06/17/2010WO2010030735A3 Stabilized coating for pharmaceutical formulations
06/17/2010WO2010025050A3 Affecting bone related conditions using cd68 blocking agents
06/17/2010WO2010015260A3 Administration by infusion for the treatment of ischemic effects
06/17/2010US20100152442 4-anilino quinazoline derivatives as antiproliferative agents
06/17/2010US20100152305 Methods of treatment of hyperuricemia and associated disease states
06/17/2010US20100152285 Flavononol Renin Inhibitor Compounds and Methods of Use Thereof
06/17/2010US20100152277 Diacylglycerol acyltransferase assay
06/17/2010US20100152276 Deuterated aminocyclohexyl ether compounds and processes for preparing same
06/17/2010US20100152275 Drug or Supplement Combination with Conjugated Linoleic Acid for Fat Loss in Mammals
1 ... 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 ... 1595